Cargando…

Naringenin Nano-Delivery Systems and Their Therapeutic Applications

Naringenin (NRG) is a polyphenolic phytochemical belonging to the class of flavanones and is widely distributed in citrus fruits and some other fruits such as bergamot, tomatoes, cocoa, and cherries. NRG presents several interesting pharmacological properties, such as anti-cancer, anti-oxidant, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhia, Mohammed, Motallebi, Mahzad, Abadi, Banafshe, Zarepour, Atefeh, Pereira-Silva, Miguel, Saremnejad, Farinaz, Santos, Ana Cláudia, Zarrabi, Ali, Melero, Ana, Jafari, Seid Mahdi, Shakibaei, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926828/
https://www.ncbi.nlm.nih.gov/pubmed/33672366
http://dx.doi.org/10.3390/pharmaceutics13020291
_version_ 1783659552041861120
author Bhia, Mohammed
Motallebi, Mahzad
Abadi, Banafshe
Zarepour, Atefeh
Pereira-Silva, Miguel
Saremnejad, Farinaz
Santos, Ana Cláudia
Zarrabi, Ali
Melero, Ana
Jafari, Seid Mahdi
Shakibaei, Mehdi
author_facet Bhia, Mohammed
Motallebi, Mahzad
Abadi, Banafshe
Zarepour, Atefeh
Pereira-Silva, Miguel
Saremnejad, Farinaz
Santos, Ana Cláudia
Zarrabi, Ali
Melero, Ana
Jafari, Seid Mahdi
Shakibaei, Mehdi
author_sort Bhia, Mohammed
collection PubMed
description Naringenin (NRG) is a polyphenolic phytochemical belonging to the class of flavanones and is widely distributed in citrus fruits and some other fruits such as bergamot, tomatoes, cocoa, and cherries. NRG presents several interesting pharmacological properties, such as anti-cancer, anti-oxidant, and anti-inflammatory activities. However, the therapeutic potential of NRG is hampered due to its hydrophobic nature, which leads to poor bioavailability. Here, we review a wide range of nanocarriers that have been used as delivery systems for NRG, including polymeric nanoparticles, micelles, liposomes, solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), nanosuspensions, and nanoemulsions. These nanomedicine formulations of NRG have been applied as a potential treatment for several diseases, using a wide range of in vitro, ex vivo, and in vivo models and different routes of administration. From this review, it can be concluded that NRG is a potential therapeutic option for the treatment of various diseases such as cancer, neurological disorders, liver diseases, ocular disorders, inflammatory diseases, skin diseases, and diabetes when formulated in the appropriate nanocarriers.
format Online
Article
Text
id pubmed-7926828
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79268282021-03-04 Naringenin Nano-Delivery Systems and Their Therapeutic Applications Bhia, Mohammed Motallebi, Mahzad Abadi, Banafshe Zarepour, Atefeh Pereira-Silva, Miguel Saremnejad, Farinaz Santos, Ana Cláudia Zarrabi, Ali Melero, Ana Jafari, Seid Mahdi Shakibaei, Mehdi Pharmaceutics Review Naringenin (NRG) is a polyphenolic phytochemical belonging to the class of flavanones and is widely distributed in citrus fruits and some other fruits such as bergamot, tomatoes, cocoa, and cherries. NRG presents several interesting pharmacological properties, such as anti-cancer, anti-oxidant, and anti-inflammatory activities. However, the therapeutic potential of NRG is hampered due to its hydrophobic nature, which leads to poor bioavailability. Here, we review a wide range of nanocarriers that have been used as delivery systems for NRG, including polymeric nanoparticles, micelles, liposomes, solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), nanosuspensions, and nanoemulsions. These nanomedicine formulations of NRG have been applied as a potential treatment for several diseases, using a wide range of in vitro, ex vivo, and in vivo models and different routes of administration. From this review, it can be concluded that NRG is a potential therapeutic option for the treatment of various diseases such as cancer, neurological disorders, liver diseases, ocular disorders, inflammatory diseases, skin diseases, and diabetes when formulated in the appropriate nanocarriers. MDPI 2021-02-23 /pmc/articles/PMC7926828/ /pubmed/33672366 http://dx.doi.org/10.3390/pharmaceutics13020291 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Bhia, Mohammed
Motallebi, Mahzad
Abadi, Banafshe
Zarepour, Atefeh
Pereira-Silva, Miguel
Saremnejad, Farinaz
Santos, Ana Cláudia
Zarrabi, Ali
Melero, Ana
Jafari, Seid Mahdi
Shakibaei, Mehdi
Naringenin Nano-Delivery Systems and Their Therapeutic Applications
title Naringenin Nano-Delivery Systems and Their Therapeutic Applications
title_full Naringenin Nano-Delivery Systems and Their Therapeutic Applications
title_fullStr Naringenin Nano-Delivery Systems and Their Therapeutic Applications
title_full_unstemmed Naringenin Nano-Delivery Systems and Their Therapeutic Applications
title_short Naringenin Nano-Delivery Systems and Their Therapeutic Applications
title_sort naringenin nano-delivery systems and their therapeutic applications
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7926828/
https://www.ncbi.nlm.nih.gov/pubmed/33672366
http://dx.doi.org/10.3390/pharmaceutics13020291
work_keys_str_mv AT bhiamohammed naringeninnanodeliverysystemsandtheirtherapeuticapplications
AT motallebimahzad naringeninnanodeliverysystemsandtheirtherapeuticapplications
AT abadibanafshe naringeninnanodeliverysystemsandtheirtherapeuticapplications
AT zarepouratefeh naringeninnanodeliverysystemsandtheirtherapeuticapplications
AT pereirasilvamiguel naringeninnanodeliverysystemsandtheirtherapeuticapplications
AT saremnejadfarinaz naringeninnanodeliverysystemsandtheirtherapeuticapplications
AT santosanaclaudia naringeninnanodeliverysystemsandtheirtherapeuticapplications
AT zarrabiali naringeninnanodeliverysystemsandtheirtherapeuticapplications
AT meleroana naringeninnanodeliverysystemsandtheirtherapeuticapplications
AT jafariseidmahdi naringeninnanodeliverysystemsandtheirtherapeuticapplications
AT shakibaeimehdi naringeninnanodeliverysystemsandtheirtherapeuticapplications